ATTAIN-PAD

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

OrforglipronOngoingRecruitingPhase 3Open NCT07223593 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…